Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy DrReddy’s Laboratories Ltd ADR stock (RDY)

Buy DrReddy’s Laboratories Ltd ADR stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

DrReddy’s Laboratories Ltd ADR is a drug manufacturers - specialty & generic business based in the US. DrReddy’s Laboratories Ltd ADR shares (RDY) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $15.37 – an increase of 6.29% over the previous week. DrReddy’s Laboratories Ltd ADR employs 27,048 staff and has a trailing 12-month revenue of around $299.9 billion.

Our top picks for where to buy DrReddy’s Laboratories Ltd ADR stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%

How to buy DrReddy’s Laboratories Ltd ADR stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – RDY. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy DrReddy’s Laboratories Ltd ADR stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

DrReddy’s Laboratories Ltd ADR stock price (NYSE: RDY)

Use our graph to track the performance of RDY stocks over time.

DrReddy’s Laboratories Ltd ADR shares at a glance

Information last updated 2024-12-19.
Latest market close$15.37
52-week range$12.63 - $16.89
50-day moving average $14.87
200-day moving average $15.12
Wall St. target price$15.34
PE ratio 18.6538
Dividend yield $8 (0.65%)
Earnings per share (TTM) $0.78

Is it a good time to buy DrReddy’s Laboratories Ltd ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

DrReddy’s Laboratories Ltd ADR price performance over time

Historical closes compared with the close of $15.12 from 2024-12-19

1 week (2024-12-13) 4.56%
1 month (2024-11-21) 8.08%
3 months (2024-09-20) -80.75%
6 months (2024-06-21) -78.87%
1 year (2023-12-21) -77.37%
2 years (2022-12-21) 51.83%
3 years (2021-12-21) 38.34%
5 years (2019-12-20) 117.53%

Is DrReddy’s Laboratories Ltd ADR stock undervalued or overvalued?

Valuing DrReddy’s Laboratories Ltd ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DrReddy’s Laboratories Ltd ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

DrReddy’s Laboratories Ltd ADR's P/E ratio

DrReddy’s Laboratories Ltd ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, DrReddy’s Laboratories Ltd ADR shares trade at around 19x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

DrReddy’s Laboratories Ltd ADR's PEG ratio

DrReddy’s Laboratories Ltd ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.5134. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into DrReddy’s Laboratories Ltd ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

DrReddy’s Laboratories Ltd ADR's EBITDA

DrReddy’s Laboratories Ltd ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $81.8 billion.

The EBITDA is a measure of a DrReddy’s Laboratories Ltd ADR's overall financial performance and is widely used to measure a its profitability.

DrReddy’s Laboratories Ltd ADR financials

Revenue TTM $299.9 billion
Operating margin TTM 22.51%
Gross profit TTM $113.8 billion
Return on assets TTM 10.4%
Return on equity TTM 19.27%
Profit margin 17.79%
Book value $366.54
Market Capitalization $12.5 billion

TTM: trailing 12 months

DrReddy’s Laboratories Ltd ADR share dividends

0%

Dividend payout ratio: 0.23% of net profits

Recently DrReddy’s Laboratories Ltd ADR has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), DrReddy’s Laboratories Ltd ADR shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In DrReddy’s Laboratories Ltd ADR's case, that would currently equate to about $8 per share.

While DrReddy’s Laboratories Ltd ADR's payout ratio might seem low, this can signify that DrReddy’s Laboratories Ltd ADR is investing more in its future growth.

DrReddy’s Laboratories Ltd ADR's most recent dividend payout was on 11 August 2024. The latest dividend was paid out to all shareholders who bought their shares by 29 July 2024 (the "ex-dividend date").

Have DrReddy’s Laboratories Ltd ADR's shares ever split?

DrReddy’s Laboratories Ltd ADR's shares were split on a 5:1 basis on 4 November 2024 . So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your DrReddy’s Laboratories Ltd ADR shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for DrReddy’s Laboratories Ltd ADR shares which in turn could have impacted DrReddy’s Laboratories Ltd ADR's share price.

DrReddy’s Laboratories Ltd ADR share price volatility

Over the last 12 months, DrReddy’s Laboratories Ltd ADR's shares have ranged in value from as little as $12.6266 up to $16.892. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while DrReddy’s Laboratories Ltd ADR's is 0.328. This would suggest that DrReddy’s Laboratories Ltd ADR's shares are less volatile than average (for this exchange).

DrReddy’s Laboratories Ltd ADR overview

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services.

Frequently asked questions

null
What percentage of DrReddy’s Laboratories Ltd ADR is owned by institutions?
Currently 14.226% of DrReddy’s Laboratories Ltd ADR shares are held by institutions.
How many people work for DrReddy’s Laboratories Ltd ADR?
Latest data suggests 27,048 work at DrReddy’s Laboratories Ltd ADR.
When does the fiscal year end for DrReddy’s Laboratories Ltd ADR?
DrReddy’s Laboratories Ltd ADR's fiscal year ends in March.
Where is DrReddy’s Laboratories Ltd ADR based?
DrReddy’s Laboratories Ltd ADR's address is: 8-2-337, Road No. 3, Hyderabad, India, 500034
What is DrReddy’s Laboratories Ltd ADR's ISIN number?
DrReddy’s Laboratories Ltd ADR's international securities identification number is: US2561352038
What is DrReddy’s Laboratories Ltd ADR's CUSIP number?
DrReddy’s Laboratories Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 256135203

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site